Senate Targets Hoarding of Drug Patents to Deter Competition

(Bloomberg) -- U.S. senators want to stop brand-name drugmakers from using an arsenal of patents to thwart generic competition, a tactic used by makers of some of the world’s most expensive and bes...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.